JP2009536191A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009536191A5 JP2009536191A5 JP2009508544A JP2009508544A JP2009536191A5 JP 2009536191 A5 JP2009536191 A5 JP 2009536191A5 JP 2009508544 A JP2009508544 A JP 2009508544A JP 2009508544 A JP2009508544 A JP 2009508544A JP 2009536191 A5 JP2009536191 A5 JP 2009536191A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- formula
- patient
- cell proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 238000000034 method Methods 0.000 claims 13
- 208000035269 cancer or benign tumor Diseases 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 206010006187 Breast cancer Diseases 0.000 claims 3
- 208000026310 Breast neoplasm Diseases 0.000 claims 3
- 206010025323 Lymphomas Diseases 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 206010033128 Ovarian cancer Diseases 0.000 claims 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 230000004663 cell proliferation Effects 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 210000002889 endothelial cell Anatomy 0.000 claims 3
- 208000032839 leukemia Diseases 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 238000010171 animal model Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229940124531 pharmaceutical excipient Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 0 CC1(*)C=CC(CCC(NC(Cc2ccccc2)*[Zn])=O)=CC=C1 Chemical compound CC1(*)C=CC(CCC(NC(Cc2ccccc2)*[Zn])=O)=CC=C1 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79910306P | 2006-05-09 | 2006-05-09 | |
| US60/799,103 | 2006-05-09 | ||
| PCT/IB2007/002471 WO2007129226A2 (en) | 2006-05-09 | 2007-05-09 | Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009536191A JP2009536191A (ja) | 2009-10-08 |
| JP2009536191A5 true JP2009536191A5 (https=) | 2011-09-08 |
| JP5225264B2 JP5225264B2 (ja) | 2013-07-03 |
Family
ID=38668152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009508544A Expired - Fee Related JP5225264B2 (ja) | 2006-05-09 | 2007-05-09 | 細胞増殖障害の処置 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20090306214A1 (https=) |
| EP (1) | EP2026775B1 (https=) |
| JP (1) | JP5225264B2 (https=) |
| AU (1) | AU2007246779B2 (https=) |
| CA (1) | CA2651375C (https=) |
| DK (1) | DK2026775T3 (https=) |
| ES (1) | ES2542344T3 (https=) |
| HU (1) | HUE026820T2 (https=) |
| IL (1) | IL195152A (https=) |
| PL (1) | PL2026775T3 (https=) |
| PT (1) | PT2026775E (https=) |
| WO (1) | WO2007129226A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642290B2 (en) * | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| JP4939396B2 (ja) * | 2004-03-26 | 2012-05-23 | ノヴァレメッド リミテッド | Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法 |
| GB0804213D0 (en) * | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| CN102821761B (zh) * | 2009-09-09 | 2015-06-10 | 诺瓦麦有限公司 | 用于治疗疼痛和炎症的n-取代的苯丙酰胺或苯丙烯酰胺 |
| US8802734B2 (en) * | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| AU2013337717B2 (en) | 2012-11-01 | 2018-10-25 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using PI3 kinase isoform modulators |
| WO2014151386A1 (en) | 2013-03-15 | 2014-09-25 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| CA2914284A1 (en) | 2013-05-30 | 2014-12-04 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
| PT3052485T (pt) | 2013-10-04 | 2021-10-22 | Infinity Pharmaceuticals Inc | Compostos heterocíclicos e suas utilizações |
| US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| US20160244452A1 (en) | 2013-10-21 | 2016-08-25 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| MX382033B (es) | 2014-03-19 | 2025-03-13 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma. |
| US20150320754A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| WO2017048702A1 (en) | 2015-09-14 | 2017-03-23 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| SG11201811237WA (en) | 2016-06-24 | 2019-01-30 | Infinity Pharmaceuticals Inc | Combination therapies |
| EA202192575A1 (ru) | 2019-03-21 | 2022-01-14 | Онксео | Соединения dbait в сочетании с ингибиторами киназ для лечения рака |
| CN114761006A (zh) | 2019-11-08 | 2022-07-15 | Inserm(法国国家健康医学研究院) | 对激酶抑制剂产生耐药性的癌症的治疗方法 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| WO2022019920A1 (en) | 2020-07-24 | 2022-01-27 | Verastem, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1908322A (en) * | 1932-04-07 | 1933-05-09 | Claude R Cook | Weed puller |
| US2908691A (en) * | 1958-07-14 | 1959-10-13 | Searle & Co | Hydroxyphenalkylaminoalkylindoles and ethers corresponding thereto |
| US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| US5539122A (en) * | 1989-05-23 | 1996-07-23 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| US7642290B2 (en) * | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| JP4939396B2 (ja) * | 2004-03-26 | 2012-05-23 | ノヴァレメッド リミテッド | Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法 |
-
2007
- 2007-05-09 JP JP2009508544A patent/JP5225264B2/ja not_active Expired - Fee Related
- 2007-05-09 AU AU2007246779A patent/AU2007246779B2/en not_active Ceased
- 2007-05-09 DK DK07804842.8T patent/DK2026775T3/en active
- 2007-05-09 CA CA2651375A patent/CA2651375C/en not_active Expired - Fee Related
- 2007-05-09 HU HUE07804842A patent/HUE026820T2/en unknown
- 2007-05-09 PT PT78048428T patent/PT2026775E/pt unknown
- 2007-05-09 EP EP07804842.8A patent/EP2026775B1/en not_active Not-in-force
- 2007-05-09 US US12/227,104 patent/US20090306214A1/en not_active Abandoned
- 2007-05-09 PL PL07804842T patent/PL2026775T3/pl unknown
- 2007-05-09 WO PCT/IB2007/002471 patent/WO2007129226A2/en not_active Ceased
- 2007-05-09 ES ES07804842.8T patent/ES2542344T3/es active Active
-
2008
- 2008-11-06 IL IL195152A patent/IL195152A/en active IP Right Grant
-
2012
- 2012-01-06 US US13/344,976 patent/US20120108666A1/en not_active Abandoned
-
2013
- 2013-10-09 US US14/049,454 patent/US20140039060A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009536191A5 (https=) | ||
| CA2651375A1 (en) | Treatment of cell proliferative disorders | |
| JP2017525730A5 (https=) | ||
| JP2012506872A5 (https=) | ||
| JP2011057693A5 (https=) | ||
| JP2013509429A5 (https=) | ||
| JP2008528671A5 (https=) | ||
| JP2008531604A5 (https=) | ||
| JP2011504903A5 (https=) | ||
| JP2010540556A5 (https=) | ||
| JP2011518202A5 (https=) | ||
| JP2011046708A5 (https=) | ||
| JP2012522841A5 (https=) | ||
| JP2012509279A5 (https=) | ||
| RU2011124894A (ru) | Триазолотиадиазоловый ингибитор протеинкиназы с-мет | |
| JP2017503753A5 (https=) | ||
| JP2004531478A5 (https=) | ||
| JP2007502832A5 (https=) | ||
| JP2013537240A5 (https=) | ||
| JP2013544892A5 (https=) | ||
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| JP2009502777A5 (https=) | ||
| JP2011527678A5 (https=) | ||
| JP2012505905A5 (https=) | ||
| JP2014511897A5 (https=) |